Openwater Achieves Quantum Leap in Medicine: Harnesses Light, Sound, and Electromagnetics to Diagnose and Treat Diseases at Cellular Level
Summary
Openwater Achieves Quantum Leap in Medicine: Harnesses Light, Sound, and Electromagnetics to Diagnose and Treat Diseases at Cellular LevelCompany Announces $100 Million in Total Funding from New and Existing Investors to Advance Medical InnovationOpenwater today announced the acceleration of its plans to commercialize its hospital-grade technology platform that integrates semiconductor physics, light, and sound to diagnose and treat diseases at the cellular level. "Preclinical and clinical studies have shown promising results, including shrinking glioblastoma tumors in mice and treating severe depression in humans. By leveraging consumer electronics manufacturing processes, Openwater is addressing the challenge of making advanced medical capabilities more accessible and affordable globally.The companys timing is crucial. The convergence of recent advancements in optoelectronics, precision electronics, and resonance-based therapies, coupled with the growing global demand for accessible and effective medical solutions, creates a unique opportunity to transform healthcare. "Openwater represents a rare confluence of transformative technology, market readiness, and global impact potential," said Deborah Jackson, Founder, Plum Alley Ventures.